Regulatory T cell control of systemic immunity and immunotherapy response in liver metastasis is a research paper published in Science Immunology (2020). On theSindex it has a DataRank of 0. It has been cited 302 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: T32 5T32AI007334-28
NIAID NIH HHS
Grant: L30 AI134628
NCI NIH HHS
Grant: L30 CA254900
NIGMS NIH HHS
Grant: T32 GM007618
NIAID NIH HHS
Grant: T32 AI007334
A.P. Giannini Foundation
Parker Institute for Cancer Immunotherapy
FWCI
10.81
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals
Additional file 1 of Angiogenic and molecular diversity determine hepatic melanoma metastasis and response to anti-angiogenic treatment
Additional file 1 of Angiogenic and molecular diversity determine hepatic melanoma metastasis and response to anti-angiogenic treatment
Additional file 2 of Angiogenic and molecular diversity determine hepatic melanoma metastasis and response to anti-angiogenic treatment
Additional file 2 of Angiogenic and molecular diversity determine hepatic melanoma metastasis and response to anti-angiogenic treatment
Additional file 1 of An international phase II trial and immune profiling of SBRT and atezolizumab in advanced pretreated colorectal cancer
Additional file 1 of An international phase II trial and immune profiling of SBRT and atezolizumab in advanced pretreated colorectal cancer